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Toxoplasma gondii is an obligate intracellular protozoan para-
site with a global distribution in humans and other mammals. 
Although this parasite most often causes subclinical infection, 
primary infection during pregnancy can induce fetal damage 
and abortion in both humans and animals. T. gondii is a well-
known inducer of type 1 cytokines, and while these cytokines 
are required to survive infection, their over-production can be 
harmful and even lethal [1,2].
Mast cells are abundant in the skin, mucosa of the digestive 
and respiratory tracts and conjunctiva. These cells provoke IgE-
mediated allergic responses and are involved in the control of 
helminth infections of the gastrointestinal tract. They play a 
key role in innate and adaptive immunity [3,4] and have been 
shown to induce acute inflammatory reactions in mice in re-
sponse to intraperitoneal injection of T. gondii [5]. Mast cells 
also protect the host when T. gondii is introduced by the oral 
route [3]. Mediators produced by activated mast cells may re-
duce acute inflammation and stimulate parasite clearance in T. 
gondii infections [6]. On the other hand, T. gondii itself inhibits 
mast cell degranulation by suppressing the mobilization of in-
tracellular Ca2+ by phospholipase C [7]. So, the overall effect of 
mast cells on T. gondii infections is uncertain. In addition, it is 
not known whether T. gondii lysates can induce inflammatory 
responses in the mast cell leukaemia cell line, HMC-1. The 
aim of this study was to evaluate whether T. gondii lysates in-
duce the activation of HMC-1 cells to release cytokines and ni-
tric oxide.
T. gondii (RH strain) tachyzoites were maintained by 
intra¬peritoneal infection of ICR mice (Osan, Korea). Tachyzo-
ites were harvested from the mice, washed with PBS and cen-
trifuged at low and high speeds (500 g and 3,000 g) for 5 min 
to remove peritoneal cells. To prepare T. gondii lysate, the 
tachyzoites were frozen and thawed 3 times and ultrasonicated 
at 100% amplitude, 0.75 cycles, 7-10 times, until the tachyzo-
ites were completely disrupted. The sonicate was centrifuged at 
10,000 g for 1 hr, and the supernatant was filtered through a 
0.2 µm membrane (Millipore, Bedford, Massachusetts, USA). 
Protein concentrations were determined with the Bradford as-
say (Bio-Rad, Hercules, California, USA).
Human leukemic mast cells (HMC-1) were grown in IMDM 
supplemented with 10% FBS at 37˚C in a 5%-CO2 incubator. 
To examine cytokine and iNOS mRNA expression, HMC-1 
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Abstract: The roles of mast cells in allergic diseases and helminth infections are well known. However, the roles of mast 
cells in T. gondii infection is poorly understood. This study was focused on the production of pro-inflammatory cytokines 
(TNF-α, IL-4), chemokines (CXCL8, MCP-1) and nitric oxide (NO) by mast cells in response to soluble lysate of T. gondii 
tachyzoites. Production of CXCL8 (IL-8), MCP-1, TNF-α and IL-4 were measured by RT-PCR and ELISA. Western blot 
were used for detection of CXCR-1 and CXCR2. Our results showed that T. gondii lysates triggered mast cells to release 
CXCL8, MCP-1, TNF-α, IL-4 and to produce NO. This suggests that mast cells play an important role in inflammatory re-
sponses to T. gondii.
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cells (1.5×106/well) were pretreated with IFN-γ (5 µg/ml, 
ProSpec, East Brunswick New Jersey, USA) for 1 hr and then 
stimulated with an aliquot of T. gondii lysate (50 µg/ml) or LPS 
(10 µg/ml, Sigma, St Louis, Missouri, USA). As a positive con-
trol, the HMC-1 cells were incubated with PMA (100 nm/ml) 
and A23187 (10 µm/ml). Total RNA was extracted from the 
cells using Trizol reagent (Invitrogen, Carlsbad, California, 
USA) and 200 µl chloroform (Sigma Aldrich, St. Louis, Mis-
souri, USA). cDNAs were synthesized and reverse-transcribed 
using RT Premix and PCR Premix (iNtRON Biotechnology, 
Seongnam, Korea). Primer sequences were as follows; β-actin 
(5́ -CCA GAG CAA GAG AGG TAT CC-3́  and 5́ -CTG TGG TGG 
TGA AGC TGT AG-3́ ), human IL-8 (5́ -GCC AAG AGA ATA 
TCC GAA CT-3́  and 5́ -AAA GTG CAA CCA CAT GTC CT-3́ ), 
MCP-1 (5́ -TCT GTG CCT GCT GCT CAT AG-3́  and 5́ -GCT 
GCA GAT TCT TGG GTT GT-3́ ), IL-4 (5́ -CCC TTT CGG CAA 
AAT CCT CC-3́  and 5́ -AGG AAT ACA GTG CAG CTT ACC 
A-3́ ), TNF-α (5́ -ACT CTT CTG CCT GCT GCA CTT TGG-3́  and 
5́ -GTT GAC CTT TGT CTG GTA GGA GAC GG-3́ ), iNOS (5́ -
AGC ATG AGC CCC TTC ATC AAT-3́  and 5́ -CTG TTT CAA 
CGA CCT CCG GG-3́ ), and GAPDH (5́ -GTC AGT GGT GGA 
CCT GAC CT-3́  and 5́ -AGG GGT CTA CAT GGC AAC TG-3́ ). 
PCR conditions were initial DNA denaturation at 94˚C for 5 
min followed by 35 rounds of denaturation at 98˚C for 15 sec, 
and annealing for 30s at 58˚C for β-actin, GAPDH & iNOS, 
56˚C for IL-8 & IL-4, 55˚C for MCP-1, and 62˚C for TNF-α, and 
extension at 72˚C for 35 sec.
To measure IL-8, MCP-1, TNF-α and IL-4 proteins, HMC-1 
cells were pretreated with IFN-γ followed by exposure to T. 
gondii lysate or LPS for 18 hr or 24 hr. Supernatants were col-
lected and stored at -20˚C and cytokines were measured by 
ELISA (BD Biosciences, San Diego, California, USA).
Western blot analysis with monoclonal antibodies was used 
to detect expression of IL-8 receptor (CXCR1 and CXCR2) on 
HMC-1 cells which were pretreated with IFN-γ for 1 hr fol-
lowed by T. gondii lysate or LPS. After incubation, the cells were 
harvested and lysed in PRO-PREP protein extraction solution 
(iNtRON Biotechnology, Seongnam, Korea). Equal amounts 
of protein were denatured and separated by SDS–PAGE on 
10% polyacrylamide gels and transferred to Immune-Blot1 
PVDF membranes (Bio-Rad, Quarry Bay, HongKong). The 
membranes were probed with anti-CXCR1 and anti-CXCR2 
antibodies (1:1,000; Abcam, Cambridge, UK), or β-actin poly-
clonal antibody (1:3,000; Abcam, Cambridge, Massachusetts, 
USA) overnight at 4˚C followed by goat anti-rabbit IgG poly-
clonal antibody (1:10,000; ADISAB-300-J, Enzo Life Sciences, 
New York, USA) for 1 hr at room temperature. The blots were 
visualized using Chemiluminescent Sensitive Plus HRP Mi-
crowell and/or Membrane Substrate (SurModics, Minneapolis, 
Minnesota, USA), and signals were measured with a Chemi-
Doc1 (Bio-Rad).
For measuring nitric oxide, HMC-1 cells was pretreated with 
IFN-γ followed by T. gondii lysate or LPS for 3 hr, 6 hr, 18 hr or 
24 hr and supernatants were collected. NO was determined as 
nitrite using Griess reagent [8].
Statistical analyses were performed with SPSS, version 21 
(IBM, Chicago, Illinois, USA). The Mann-Whitney U test was 
used to compare results, and P-values<0.05 were considered 
statistically significant. Data are expressed as means±SDs of 
three independent experiments.
In this experiment, up-regulation of IL-8 mRNA and in-
creased secretion of IL-8 were observed in the T. gondii-treated 
HMC-1 cells 6 hr and 18 hr post inoculation (PI), respectively. 
However the IL-8 levels of HMC-1 cells stimulated with LPS as 
positive control were significantly higher than those of the of T. 
gondii-stimulated cells. Up-regulations of MCP-1 mRNA and 
protein were also observed in the HMC-1 cells exposed to T. 
gondii lysate or LPS. Similarly, enhanced TNF-α mRNA expres-
sion and increased TNF-α secretion were noted in supernatants 
of HMC-1 cells treated with T. gondii lysate. IL-4 mRNA was 
also increased by incubation with T. gondii lysate for 24 hr, and 
IL-4 protein increased in the supernatants of treated HMC-1 
cells (Fig. 1A, B). To investigate the expression of chemokine 
receptors for IL-8, CXCR1 and CXCR2 production was ana-
lyzed by western blotting after treatment of HMC-1 cells with 
T. gondii lysate or LPS for 1 hr. Both CXCR1 and CXCR2 in-
creased in response to T. gondii lysate (Fig. 1C).
The results in Fig. 2A show that iNOS mRNA increased in 
HMC-1 cells treated with T. gondii lysate for 3 hr, and then 
gradually disappeared. In LPS-treated cells, iNOS mRNA con-
tinued to increase between 3 hr and 24 hr of incubation al-
though at a decreasing rate. Maximal NO production in HMC-
1 cells treated with T. gondii lysate or LPS was observed after 3 
hr of stimulation (Fig. 2B).
In T. gondii infections, immune cells including neutrophils, 
monocytes and macrophages are activated, and also these cells 
are targets of T. gondii [9,10]. T. gondii down-regulates type I 
immune responses, blocking production of pro-inflammatory 
cytokine including IFN-γ in macrophages and dendritic cells 
[11]. Mast cells are abundant in the intestinal mucosa and play 
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Fig. 1. Increased production of IL-8, MCP-1, TNF-α and IL-4 mRNAs and proteins by HMC-1 cells incubated with T. gondii lysate. 
HMC-1 cells were pretreated with IFN-γ for 1 hr and then stimulated with T. gondii lysate or LPS. mRNA expression of each cytokine (A) 
and cytokine level (B) were increased. CXCR1 and CXCR2 was measured by western blotting with monoclonal antibodies to each re-
ceptor after 1 hr of treatment with T. gondii lysate. PMA +A23187 was used as positive control. M, culture supernatant of HMC-1 alone; 
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an important role in protective immune responses to oral in-
fection by T. gondii [3]. Exposure to T. gondii causes mast cell to 
activate, degranulate and release mediators, proteases and cy-
tokines [12]. Increases in mast cells numbers may be involved 
in the balance between inflammation and wound healing 
[13].
In the current study we found that IL-8 and MCP-1 secretion 
was up-regulated after 18 hr exposure to T. gondii lysate. This 
result is in agreement with our previous report that infection 
with T. gondii tachyzoites leads to increased secretion of IL-8 
and MCP-1 by HeLa cells and fibroblasts [14]. Up-regulation 
of TNF-α and IL-4 mRNAs was observed in HMC-1 cells treat-
ed with T. gondii lysate for 18 hr and 24 hr, respectively. Pro-
duction of both cytokines increased in T. gondii lysate- or LPS-
treated HMC-1 cells indicating that T. gondii lysate induces in-
flammatory effect in the cells. T. gondii lysate alone did not in-
crease cytokine production in HMC-1 cells. However, pre-
treatment of IFN- γ resulted in increased cytokine production 
in the cells. Therefore, IFN-γ was thought to be acted as a trig-
ger for HMC-1 cells in cytokine production by T. gondii lysate.
The functions of chemokines induced by intracellular 
pathogens include leukocyte recruitment, cell mediated im-
munity and anti-protozoal activity. IL-8 induces a rapid and 
transient increase of Ca2+ in mast cells. HMC-1 cells express 
the CXCL8 chemokine receptors, CXCR1 and CXCR2 [15-18]. 
Increased levels of these receptors were observed on HMC-1 
Fig. 2. iNOS mRNA and nitric oxide (NO) productions were up-regulated by HMC-1 cells stimulated with T. gondii lysate. HMC-1 cells 
were pretreated with IFN-γ for 1 hr and then stimulated with T. gondii lysate or LPS. iNOS mRNA (A) and NO production (B) were deter-
mined after 3 hr, 6 hr, 18 hr, and 24 hr of incubation. NO production was measured with Griess reagent. PMA +A23187 was used as 
positive control. M, culture supernatant of HMC-1 cells alone; M*, culture supernatant of HMC-1 cells treated with IFN-γ; TgL, T. gondii 
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cells stimulated with T. gondii lysate for 1 hr (Fig. 1C). 
The release of mediators by mast cell activation plays an im-
portant role in modulating inflammation during T. gondii in-
fection [6,16]. In protozoal infections these mast cells are 
characterized by degranulation and the production of pro-in-
flammatory mediators, such as TNF-α [13]. The mast cell acti-
vator, compound 48/80, up-regulated Th1 cytokine mRNA 
(IFN-γ, IL-12p40, TNF-α), and the mast cell stabilizer, disodi-
um cromoglycate, increased Th2 cytokine mRNA (IL-4, IL-10) 
[12]. 
Mast cells are effector cells involved in clearance of parasites 
including Trichomonas vaginalis (T. vaginalis) [6]. We observed 
that rat peritoneal mast cells (RPMCs) were involved in the in-
flammatory response to T. vaginalis infection. Increased release 
of histamine and TNF-α were observed in RPMC-stimulated T. 
vaginalis ESP or live trichomonads [19]. Activation of mast 
cells has been reported to trigger production of cytokines and 
inflammatory mediators by protozoan parasites such as Plas-
modium sp., Leishmania sp., and T. gondii [12].
Several protozoan parasites have evolved strategies to evade 
NO-mediated anti-microbicidal activity. Inducible nitric oxide 
synthase (iNOS)-derived NO can inhibit leucocyte adhesion 
in the micro-vasculature during ongoing inflammation. T. gon-
dii infection partially inhibits NO production by murine mac-
rophages and thus promotes parasite survival in phagocytic 
cells [12,20,21]. Leishimania sp. and Trypanosoma cruzi are 
known to inhibit iNOS expression [22,23]. We investigated 
HMC-1 cells were treated with T. gondii lysate to determine 
whether T. gondii infection affects NO production. Increased 
iNOS mRNA and NO production were observed at 3 hr PI and 
it then declined by 6 hr. 
Mast cells induce recruitment of other immune cells to initi-
ate inflammation. In the present study, we observed that T. 
gondii lysate stimulated the production of chemokines 
(CXCL8, MCP-1), cytokines (TNF-α, IL-4) and NO production 
in HMC-1 cells. Therefore, activated mast cells by T. gondii ly-
sate may be involved in innate and adaptive immune respons-
es against T. gondii infection. 
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